AAPL353.11+21.21 (+6.39%) ▲|ABBV285.72-0.28 (-0.10%) ▼|ABT114.57+5.17 (+4.73%) ▲|ACN265.25+10.69 (+4.20%) ▲|ADBE252.87+6.73 (+2.73%) ▲|AMAT370.29-11.63 (-3.05%) ▼|AMD486.66+2.76 (+0.57%) ▲|AMGN473.30+12.04 (+2.61%) ▲|AMT195.14+7.85 (+4.19%) ▲|AMZN266.71+16.02 (+6.39%) ▲|AVGO326.33-5.80 (-1.75%) ▼|AXP331.89+6.39 (+1.96%) ▲|BA176.92+3.61 (+2.08%) ▲|BAC51.57+1.91 (+3.85%) ▲|BKNG172.39+16.72 (+10.74%) ▲|BLK1,216.59+55.27 (+4.76%) ▲|BMY63.02+1.31 (+2.12%) ▲|BNY149.93+0.62 (+0.41%) ▲|BRK-B572.73+15.66 (+2.81%) ▲|C125.21+2.50 (+2.04%) ▲|CAT583.50-40.44 (-6.48%) ▼|CL99.32+3.70 (+3.87%) ▲|CMCSA24.91+1.24 (+5.22%) ▲|COF203.97-4.75 (-2.27%) ▼|COP137.90-6.50 (-4.50%) ▼|COST1,050.06+30.80 (+3.02%) ▲|CRM228.20+6.00 (+2.70%) ▲|CSCO102.61-0.36 (-0.35%) ▼|CVS81.22-10.19 (-11.15%) ▼|CVX217.92-7.35 (-3.26%) ▼|DE662.93-2.90 (-0.44%) ▼|DHR232.12+2.01 (+0.87%) ▲|DIS119.86+5.68 (+4.97%) ▲|DUK129.64+3.13 (+2.47%) ▲|EMR168.37+1.98 (+1.19%) ▲|FDX322.80+4.78 (+1.50%) ▲|GD363.39-11.11 (-2.97%) ▼|GE323.01+2.34 (+0.73%) ▲|GEV812.57-105.64 (-11.50%) ▼|GILD173.37+5.90 (+3.52%) ▲|GM93.09+4.75 (+5.38%) ▲|GOOG289.52+11.25 (+4.04%) ▲|GOOGL291.28+11.25 (+4.02%) ▲|GS917.09+21.00 (+2.34%) ▲|HD349.60+15.94 (+4.78%) ▲|HON226.45+2.40 (+1.07%) ▲|IBM256.19+6.15 (+2.46%) ▲|INTC57.56-3.00 (-4.95%) ▼|INTU361.98+17.26 (+5.01%) ▲|ISRG482.60+41.85 (+9.50%) ▲|JNJ272.93+6.76 (+2.54%) ▲|JPM349.84+11.86 (+3.51%) ▲|KO96.17+1.37 (+1.44%) ▲|LIN523.87+12.32 (+2.41%) ▲|LLY1,431.00+21.62 (+1.53%) ▲|LMT598.56-40.44 (-6.33%) ▼|LOW227.36+13.98 (+6.55%) ▲|LRCX225.05-5.67 (-2.46%) ▼|MA669.09+21.91 (+3.39%) ▲|MCD276.90+13.86 (+5.27%) ▲|MDLZ67.85+2.73 (+4.19%) ▲|MDT104.45+5.57 (+5.63%) ▲|META629.26+8.23 (+1.33%) ▲|MMM192.08+15.03 (+8.49%) ▲|MO78.42+1.48 (+1.92%) ▲|MRK148.47+3.80 (+2.63%) ▲|MS191.00+4.91 (+2.64%) ▲|MSFT553.68+32.69 (+6.27%) ▲|MU804.52-50.58 (-5.92%) ▼|NEE88.10+3.77 (+4.47%) ▲|NFLX66.07+2.65 (+4.17%) ▲|NKE40.67+2.19 (+5.68%) ▲|NOW109.90+0.74 (+0.68%) ▲|NVDA202.58-4.11 (-1.99%) ▼|ORCL125.60-0.59 (-0.47%) ▼|PEP143.51+6.24 (+4.55%) ▲|PFE30.52+0.52 (+1.73%) ▲|PG167.56+5.50 (+3.39%) ▲|PLTR171.38-4.02 (-2.29%) ▼|PM211.56+3.53 (+1.70%) ▲|QCOM165.57+1.14 (+0.69%) ▲|RTX195.21-8.61 (-4.22%) ▼|SBUX108.67+3.90 (+3.72%) ▲|SCHW92.63+3.35 (+3.75%) ▲|SO92.27-1.48 (-1.58%) ▼|SPG227.15+5.07 (+2.28%) ▲|T22.00+0.61 (+2.83%) ▲|TMO701.50+3.16 (+0.45%) ▲|TMUS160.11+5.70 (+3.69%) ▲|TSLA382.71-15.79 (-3.96%) ▼|TXN308.07-4.42 (-1.41%) ▼|UBER71.43+4.83 (+7.25%) ▲|UNH404.65+0.21 (+0.05%) ▲|UNP305.39+1.96 (+0.64%) ▲|UPS113.61+4.44 (+4.06%) ▲|USB60.50+0.61 (+1.02%) ▲|V432.75+12.33 (+2.93%) ▲|VZ46.41+1.17 (+2.58%) ▲|WFC86.69+1.16 (+1.35%) ▲|WMT130.01+5.15 (+4.12%) ▲|XOM170.81-6.66 (-3.75%) ▼|AAPL353.11+21.21 (+6.39%) ▲|ABBV285.72-0.28 (-0.10%) ▼|ABT114.57+5.17 (+4.73%) ▲|ACN265.25+10.69 (+4.20%) ▲|ADBE252.87+6.73 (+2.73%) ▲|AMAT370.29-11.63 (-3.05%) ▼|AMD486.66+2.76 (+0.57%) ▲|AMGN473.30+12.04 (+2.61%) ▲|AMT195.14+7.85 (+4.19%) ▲|AMZN266.71+16.02 (+6.39%) ▲|AVGO326.33-5.80 (-1.75%) ▼|AXP331.89+6.39 (+1.96%) ▲|BA176.92+3.61 (+2.08%) ▲|BAC51.57+1.91 (+3.85%) ▲|BKNG172.39+16.72 (+10.74%) ▲|BLK1,216.59+55.27 (+4.76%) ▲|BMY63.02+1.31 (+2.12%) ▲|BNY149.93+0.62 (+0.41%) ▲|BRK-B572.73+15.66 (+2.81%) ▲|C125.21+2.50 (+2.04%) ▲|CAT583.50-40.44 (-6.48%) ▼|CL99.32+3.70 (+3.87%) ▲|CMCSA24.91+1.24 (+5.22%) ▲|COF203.97-4.75 (-2.27%) ▼|COP137.90-6.50 (-4.50%) ▼|COST1,050.06+30.80 (+3.02%) ▲|CRM228.20+6.00 (+2.70%) ▲|CSCO102.61-0.36 (-0.35%) ▼|CVS81.22-10.19 (-11.15%) ▼|CVX217.92-7.35 (-3.26%) ▼|DE662.93-2.90 (-0.44%) ▼|DHR232.12+2.01 (+0.87%) ▲|DIS119.86+5.68 (+4.97%) ▲|DUK129.64+3.13 (+2.47%) ▲|EMR168.37+1.98 (+1.19%) ▲|FDX322.80+4.78 (+1.50%) ▲|GD363.39-11.11 (-2.97%) ▼|GE323.01+2.34 (+0.73%) ▲|GEV812.57-105.64 (-11.50%) ▼|GILD173.37+5.90 (+3.52%) ▲|GM93.09+4.75 (+5.38%) ▲|GOOG289.52+11.25 (+4.04%) ▲|GOOGL291.28+11.25 (+4.02%) ▲|GS917.09+21.00 (+2.34%) ▲|HD349.60+15.94 (+4.78%) ▲|HON226.45+2.40 (+1.07%) ▲|IBM256.19+6.15 (+2.46%) ▲|INTC57.56-3.00 (-4.95%) ▼|INTU361.98+17.26 (+5.01%) ▲|ISRG482.60+41.85 (+9.50%) ▲|JNJ272.93+6.76 (+2.54%) ▲|JPM349.84+11.86 (+3.51%) ▲|KO96.17+1.37 (+1.44%) ▲|LIN523.87+12.32 (+2.41%) ▲|LLY1,431.00+21.62 (+1.53%) ▲|LMT598.56-40.44 (-6.33%) ▼|LOW227.36+13.98 (+6.55%) ▲|LRCX225.05-5.67 (-2.46%) ▼|MA669.09+21.91 (+3.39%) ▲|MCD276.90+13.86 (+5.27%) ▲|MDLZ67.85+2.73 (+4.19%) ▲|MDT104.45+5.57 (+5.63%) ▲|META629.26+8.23 (+1.33%) ▲|MMM192.08+15.03 (+8.49%) ▲|MO78.42+1.48 (+1.92%) ▲|MRK148.47+3.80 (+2.63%) ▲|MS191.00+4.91 (+2.64%) ▲|MSFT553.68+32.69 (+6.27%) ▲|MU804.52-50.58 (-5.92%) ▼|NEE88.10+3.77 (+4.47%) ▲|NFLX66.07+2.65 (+4.17%) ▲|NKE40.67+2.19 (+5.68%) ▲|NOW109.90+0.74 (+0.68%) ▲|NVDA202.58-4.11 (-1.99%) ▼|ORCL125.60-0.59 (-0.47%) ▼|PEP143.51+6.24 (+4.55%) ▲|PFE30.52+0.52 (+1.73%) ▲|PG167.56+5.50 (+3.39%) ▲|PLTR171.38-4.02 (-2.29%) ▼|PM211.56+3.53 (+1.70%) ▲|QCOM165.57+1.14 (+0.69%) ▲|RTX195.21-8.61 (-4.22%) ▼|SBUX108.67+3.90 (+3.72%) ▲|SCHW92.63+3.35 (+3.75%) ▲|SO92.27-1.48 (-1.58%) ▼|SPG227.15+5.07 (+2.28%) ▲|T22.00+0.61 (+2.83%) ▲|TMO701.50+3.16 (+0.45%) ▲|TMUS160.11+5.70 (+3.69%) ▲|TSLA382.71-15.79 (-3.96%) ▼|TXN308.07-4.42 (-1.41%) ▼|UBER71.43+4.83 (+7.25%) ▲|UNH404.65+0.21 (+0.05%) ▲|UNP305.39+1.96 (+0.64%) ▲|UPS113.61+4.44 (+4.06%) ▲|USB60.50+0.61 (+1.02%) ▲|V432.75+12.33 (+2.93%) ▲|VZ46.41+1.17 (+2.58%) ▲|WFC86.69+1.16 (+1.35%) ▲|WMT130.01+5.15 (+4.12%) ▲|XOM170.81-6.66 (-3.75%) ▼|
19.7 C
New York
Wednesday, November 4, 2026

Tag: time

newsFORsourcecompanycontentinformationreleases1market

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma...

TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

NEW YORK, June 13, 2026 /PRNewswire/ -- Travel And Tour World (TTW) today announced its Top 50 Amusement Park Travel Destinations in the World...

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

GOTHENBURG, Sweden, June 13, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation...

Canada’s Largest Athletic Fundraiser Raises a Record $23.3 Million in Support of The Princess Margaret Cancer Foundation

More than 4800 cyclists set a new fundraising record to create a world free from the fear of cancer TORONTO, June 13, 2026 /CNW/...

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).

PureHealth Research Utilizes Bioavailable Cranberry and Astragalus in Premium Natural Supplements for Kidney Health

MANASSAS, Va., June 13, 2026 /PRNewswire/ -- PureHealth Research today addressed the growing demand for proactive kidney wellness with its collection of science-backed renal...

Growing Consumer Interest in Natural Supplements for Thyroid Health Leads PureHealth Research to Highlight Iodine, Selenium, and Ashwagandha

MANASSAS, Va., June 13, 2026 /PRNewswire/ -- PureHealth Research is spotlighting rising consumer interest in proactive thyroid wellness and the role of targeted nutritional...

Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed. 
Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.

YEEDI Delivers Lowest-Ever Pricing on Self-Cleaning Roller Mop Robot Vacuums With Early Prime Day Deals

Starting June 13, M14 PLUS and S14 PLUS Drop to $399.99, Bringing Advanced Self-Cleaning Roller Mop Technology Into the Sub-$400 SegmentSAN FRANCISCO, June 13,...

Don’t Pay Full Price for Power: WattCycle’s Prime Day Event Drops Up to 70% Off LiFePO4 Batteries Starting June 15

WattCycle’s June 15-30 sale offers up to 70% off LiFePO4 batteries. Enjoy new arrivals, double points, giveaways & 8% off code: WattCyclePrimeDay.

GOOD WORKS, GIVING, AND GLAMOUR SHINE AT NORTH SHORE ANIMAL LEAGUE AMERICA’S RESCUE GALA CELEBRATING ANIMAL RESCUE AND ADOPTION

Attendees Included Event Chairperson Beth Stern, Event Host Will Ganss, Event Entertainer Joshua Radin, Liz Gillies, The Dogist (Elias Weiss Friedman,) and Others.  Proceeds...

SpaceX perpetual futures become Binance’s No. 2 traded product; Binance captures over 60% market share across CEX and DEX venues

Binance exceeded $5.6 billion in SPCXUSDT trading volume over last 24 hours, with over $9 billion in accumulated trading volume across SpaceX's Pre-IPO and...

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

BEERSE, BELGIUM, June 13, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced results from the investigational Phase 3 MonumenTAL-3 study.1 The results showed that TALVEY® (talquetamab), a GPRC5D bispecific antibody, in combination with daratumumab with or without pomalidomide demonstrated significant reduction in the risk of disease progression or death of up to 72.0%, and clinically meaningful reduction of up to 53.0% in the risk of death, compared to the standard regimen of daratumumab, pomalidomide, and dexamethasone (DPd) in patients with relapsed or refractory multiple myeloma (RRMM).1 Results showed a progression-free survival (PFS) rate of up to 81.3% versus standard of care (51.2%) and an overall survival (OS) rate of up to 89.2% versus standard of care (79.1%) at 24 months.1  

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

TALVEY® plus DARZALEX FASPRO® with or without pomalidomide showed progression-free survival of up to 81% and overall survival of up to 89% at 24 monthsMonumenTAL-3 is the...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTime

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers